City

Houston (1)

Jacksonville (1)

Rochester (1)

Scottsdale (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

M.D. Anderson Cancer Center (1)

Mayo Clinic (1)

Collaborator

National Cancer Institute (NCI) (2)

Intervention

avelumab (1)

cisplatin (1)

erlotinib hydrochloride (1)

fluorouracil (1)

mitomycin (1)

quality-of-life assessment (1)

radiation therapy (1)

Study Documents

Intervention Type

drug (2)

other (1)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

stage ii urethral cancer ajcc v8

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Stage II Bladder Cancer AJCC v8, Stage II Renal Pelvis Cancer

Completed

Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
+11 more

Avelumab
+5 more

Scottsdale, Arizona
+2 more

Mar 12, 2021

Recurrent Bladder Urothelial Carcinoma, Recurrent Renal Pelvis Urothelial Carcinoma, Recurrent Ureter Urothelial Carcinoma Trial

Completed

Recurrent Bladder Urothelial Carcinoma
+19 more

Erlotinib Hydrochloride

Houston, Texas

M D Anderson Cancer Center

Aug 21, 2020